Stock CRM PZ CORMAY S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials PZ Cormay S.A.

Equities

CRM

PLCMRAY00029

Medical Equipment, Supplies & Distribution

Market Closed - Warsaw S.E.
Other stock markets
 11:55:52 2024-05-02 EDT 		5-day change 1st Jan Change
0.59 PLN +0.34% Intraday chart for PZ Cormay S.A. -2.32% +0.34%
2023 PZ Cormay S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 PZ Cormay S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 117.4 93.47 84.37 96.84 96.84 74.69
Enterprise Value (EV) 1 117.4 93.69 48.11 85.84 92.45 68.39
P/E ratio -49.3 x -3.48 x -2.08 x -7.65 x 60.5 x -11.4 x
Yield - - - - - -
Capitalization / Revenue 1.51 x 1.34 x 1.23 x 1.48 x 1.14 x 0.87 x
EV / Revenue 1.51 x 1.34 x 0.7 x 1.31 x 1.09 x 0.8 x
EV / EBITDA -250 x -71.6 x 11.2 x -998 x 31.9 x -48.3 x
EV / FCF -22.7 x -1.76 x 1.1 x 6.84 x -19.4 x 12.9 x
FCF Yield -4.41% -56.8% 90.7% 14.6% -5.16% 7.75%
Price to Book 0.91 x 0.84 x 1.17 x 1.55 x 1.49 x 1.22 x
Nbr of stocks (in thousands) 77,205 84,205 84,205 84,205 84,205 84,205
Reference price 2 1.520 1.110 1.002 1.150 1.150 0.8870
Announcement Date 18-04-27 19-04-13 20-04-24 21-04-23 22-04-22 23-03-30
1PLN in Million2PLN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 77.58 69.79 68.41 65.29 84.73 85.36
EBITDA 1 -0.47 -1.308 4.288 -0.086 2.902 -1.416
EBIT 1 -4.869 -5.663 1.702 -2.981 0.092 -4.376
Operating Margin -6.28% -8.11% 2.49% -4.57% 0.11% -5.13%
Earnings before Tax (EBT) 1 -1.901 -24.87 -41.13 -12.7 1.757 -6.242
Net income 1 -2.021 -24.98 -40.54 -12.66 1.635 -6.568
Net margin -2.6% -35.79% -59.25% -19.4% 1.93% -7.69%
EPS 2 -0.0309 -0.3187 -0.4814 -0.1504 0.0190 -0.0780
Free Cash Flow 1 -5.179 -53.21 43.64 12.56 -4.766 5.299
FCF margin -6.67% -76.24% 63.8% 19.23% -5.63% 6.21%
FCF Conversion (EBITDA) - - 1,017.79% - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 18-04-27 19-04-13 20-04-24 21-04-23 22-04-22 23-03-30
1PLN in Million2PLN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 0.09 0.23 - - - -
Net Cash position 1 - - 36.3 11 4.38 6.3
Leverage (Debt/EBITDA) -0.1979 x -0.1728 x - - - -
Free Cash Flow 1 -5.18 -53.2 43.6 12.6 -4.77 5.3
ROE (net income / shareholders' equity) -1.57% -19.6% -42.6% -18.7% 2.6% -10.5%
ROA (Net income/ Total Assets) -1.68% -2.11% 0.81% -1.9% 0.06% -2.71%
Assets 1 120.6 1,186 -5,030 666.9 2,753 242.1
Book Value Per Share 2 1.670 1.330 0.8600 0.7400 0.7700 0.7300
Cash Flow per Share 2 0.0300 0.0300 0.0900 0.1200 0.0300 0.0200
Capex 1 1.29 1.13 1.4 0.18 4.45 2.48
Capex / Sales 1.66% 1.62% 2.04% 0.28% 5.25% 2.91%
Announcement Date 18-04-27 19-04-13 20-04-24 21-04-23 22-04-22 23-03-30
1PLN in Million2PLN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Diagnostic & Testing Substances

1st Jan change Capi.
PZ CORMAY S.A. Stock PZ Cormay S.A.
+0.34% 12.37M
BIOMÉRIEUX Stock bioMérieux
-1.89% 12.56B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-9.59% 7.68B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
-1.31% 5.29B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+21.82% 5.18B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
+0.02% 4.57B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-50.89% 3.29B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+6.42% 2.6B
VITROLIFE AB Stock Vitrolife AB
-10.02% 2.2B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-8.29% 1.79B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. CRM Stock
  4. Financials PZ Cormay S.A.